Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

1articles mentioning drugs

3drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: NM32-2668 ×

NM32-2668

This drug is selected. Its supporting articles are shown below.

Articles mentioning NM32-2668

1 articles · page 1 of 1

517 A phase 1 trial of NM32–2668, a ROR1-CD3-HSA trispecific T-cell engager in patients with ROR1-expressing solid tumors

jitc · abstract · 2025-11-04 · 3 matching annotations

98.1%

NM32-2668 NM32-2668-101 TCE esophageal cancer Johns Hopkins University School of Medicine Moffitt Cancer Center University of Wisconsin Carbone Cancer Center mesothelioma Albert Einstein Cancer Center The University of Texas MD Anderson Cancer Center+2 more

…dynamics, immunogenicity, and preliminary antitumor activity of NM32-2668 monotherapy administered every two weeks to patients with ROR1-…